In light of FKBPL’s critical role in developmental, physiological, and pathological angiogenesis as an anti-angiogenic protein (18) via CD44 (17), we investigated both FKBPL and CD44 expression in placental samples from women with and without preeclampsia (Cohort 2, Table 2). This evidence concerns the gene CD44 and preeclampsia.